<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37283936</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2699-4445</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Free neuropathology</Title><ISOAbbreviation>Free Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Neuromuscular disease: 2023 update.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.17879/freeneuropathology-2023-4682</ELocationID><Abstract><AbstractText>This review highlights ten important advances in the neuromuscular disease field that were reported in 2022. As with prior updates in this article series, the overarching topics include (i) advances in understanding of fundamental neuromuscular biology; (ii) new / emerging diseases; (iii) advances in understanding of disease etiology and pathogenesis; (iv) diagnostic advances; and (v) therapeutic advances. Within this general framework, the individual disease entities that are discussed in more detail include neuromuscular complications of COVID-19 (another look at the topic first covered in the 2021 and 2022 reviews), DNAJB4-associated myopathy, NMNAT2-deficient hereditary axonal neuropathy, Guillain-Barr&#xe9; syndrome, sporadic inclusion body myositis, and amyotrophic lateral sclerosis. In addition, the review highlights a few other advances (including new insights into mechanisms of fiber maturation during muscle regeneration and fiber rebuilding following reinnervation, improved genetic testing methods for facioscapulohumeral and myotonic muscular dystrophies, and the use of SARM1 inhibitors to block Wallerian degeneration) that will be of significant interest for clinicians and researchers who specialize in neuromuscular disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Margeta</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Free Neuropathol</MedlineTA><NlmUniqueID>101768755</NlmUniqueID><ISSNLinking>2699-4445</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Chaperonopathy</Keyword><Keyword MajorTopicYN="N">Facioscapulohumeral dystrophy</Keyword><Keyword MajorTopicYN="N">Guillain-Barr&#xe9; syndrome</Keyword><Keyword MajorTopicYN="N">Inclusion body myositis</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Muscle regeneration</Keyword><Keyword MajorTopicYN="N">Myotonic dystrophy</Keyword><Keyword MajorTopicYN="N">Nodes of Ranvier</Keyword><Keyword MajorTopicYN="N">Target fiber</Keyword><Keyword MajorTopicYN="N">Wallerian degeneration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>9</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37283936</ArticleId><ArticleId IdType="pmc">PMC10209858</ArticleId><ArticleId IdType="doi">10.17879/freeneuropathology-2023-4682</ArticleId><ArticleId IdType="pii">4-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrams, R.M.C., Simpson, D.M., Navis, A., Jette, N., Zhou, L., and Shin, S.C. (2022). Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve 65, 440-443. 10.1002/mus.27458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom, A.J., Mao, X., Strickland, A., Sasaki, Y., Milbrandt, J., and DiAntonio, A. (2022). Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients. Mol Neurodegener 17, 1. 10.1186/s13024-021-00511-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00511-x</ArticleId><ArticleId IdType="pmc">PMC8739729</ArticleId><ArticleId IdType="pubmed">34991663</ArticleId></ArticleIdList></Reference><Reference><Citation>Blume, G., Pestronk, A., Frank, B., and Johns, D.R. (1997). Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 120, 39-45. 10.1093/brain/120.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.1.39</ArticleId><ArticleId IdType="pubmed">9055796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosanac, T., Hughes, R.O., Engber, T., Devraj, R., Brearley, A., Danker, K., Young, K., Kopatz, J., Hermann, M., Berthemy, A., et al. (2021). Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy. Brain 144, 3226-3238. 10.1093/brain/awab184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab184</ArticleId><ArticleId IdType="pmc">PMC8634121</ArticleId><ArticleId IdType="pubmed">33964142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratkowski, M., Burdett, T.C., Danao, J., Wang, X., Mathur, P., Gu, W., Beckstead, J.A., Talreja, S., Yang, Y.S., Danko, G., et al. (2022). Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron 110, 3711-3726. 10.1016/j.neuron.2022.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.08.017</ArticleId><ArticleId IdType="pubmed">36087583</ArticleId></ArticleIdList></Reference><Reference><Citation>Britson, K.A., Ling, J.P., Braunstein, K.E., Montagne, J.M., Kastenschmidt, J.M., Wilson, A., Ikenaga, C., Tsao, W., Pinal-Fernandez, I., Russell, K.A., et al. (2022). Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med 14, eabi9196. 10.1126/scitranslmed.abi9196</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi9196</ArticleId><ArticleId IdType="pmc">PMC9118725</ArticleId><ArticleId IdType="pubmed">35044790</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti, L., Gilley, J., and Coleman, M.P. (2014). Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 15, 394-409. 10.1038/nrn3680</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3680</ArticleId><ArticleId IdType="pubmed">24840802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings, B.B., Marshall, J.L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A.R., Bolduc, V., Waddell, L.B., Sandaradura, S.A., O'Grady, G.L., et al. (2017). Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med 9, eaal5209. 10.1126/scitranslmed.aal5209</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aal5209</ArticleId><ArticleId IdType="pmc">PMC5548421</ArticleId><ArticleId IdType="pubmed">28424332</ArticleId></ArticleIdList></Reference><Reference><Citation>De Reuck, J., De Coster, W., and vander Eecken, H. (1977). The target phenomenon in rat muscle following tenotomy and neurotomy. A comparative light microscopic and histochemical study. Acta Neuropathol 37, 49-53. 10.1007/BF00684540</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00684540</ArticleId><ArticleId IdType="pubmed">190847</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingwall, C.B., Strickland, A., Yum, S.W., Yim, A.K., Zhu, J., Wang, P.L., Yamada, Y., Schmidt, R.E., Sasaki, Y., Bloom, A.J., et al. (2022). Macrophage depletion blocks congenital SARM1-dependent neuropathy. J Clin Invest 132, e159800. 10.1172/JCI159800</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI159800</ArticleId><ArticleId IdType="pmc">PMC9711884</ArticleId><ArticleId IdType="pubmed">36287209</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel, W.K. (1961). Muscle target fibres, a newly recognized sign of denervation. Nature 191, 389-390. 10.1038/191389a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/191389a0</ArticleId><ArticleId IdType="pubmed">13696814</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdmann, H., Scharf, F., Gehling, S., Benet-Pages, A., Jakubiczka, S., Becker, K., Seipelt, M., Kleefeld, F., Knop, K.C., Prott, E.C., et al. (2022). Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy. Brain, Epub ahead of print. 10.1093/brain/awac336</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac336</ArticleId><ArticleId IdType="pubmed">36100962</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman, H.C., Merlini, E., Guijas, C., DeMeester, K.E., Njomen, E., Kozina, E.M., Yokoyama, M., Vinogradova, E., Reardon, H.T., Melillo, B., et al. (2022). Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. Proc Natl Acad Sci U S A 119, e2208457119. 10.1073/pnas.2208457119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2208457119</ArticleId><ArticleId IdType="pmc">PMC9436332</ArticleId><ArticleId IdType="pubmed">35994671</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley, M.D., Gu, W., Nanson, J.D., Shi, Y., Sasaki, Y., Cunnea, K., Malde, A.K., Jia, X., Luo, Z., Saikot, F.K., et al. (2021). SARM1 is a metabolic sensor activated by an increased NMN/NAD(+) ratio to trigger axon degeneration. Neuron 109, 1118-1136. 10.1016/j.neuron.2021.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC8174188</ArticleId><ArticleId IdType="pubmed">33657413</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley, J., Jackson, O., Pipis, M., Estiar, M.A., Al-Chalabi, A., Danzi, M.C., van Eijk, K.R., Goutman, S.A., Harms, M.B., Houlden, H., et al. (2021). Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife 10, e70905. 10.7554/eLife.70905</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70905</ArticleId><ArticleId IdType="pmc">PMC8735862</ArticleId><ArticleId IdType="pubmed">34796871</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal, N.A., Coulis, G., Duarte, J., Farahat, P.K., Mannaa, A.H., Cauchii, J., Irani, T., Araujo, N., Wang, L., Wencel, M., et al. (2022). Immunophenotyping of inclusion body myositis blood T and NK cells. Neurology 98, e1374-e1383. 10.1212/WNL.0000000000200013</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200013</ArticleId><ArticleId IdType="pmc">PMC8967422</ArticleId><ArticleId IdType="pubmed">35131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg, S.A., Pinkus, J.L., Kong, S.W., Baecher-Allan, C., Amato, A.A., and Dorfman, D.M. (2019). Highly differentiated cytotoxic T cells in inclusion body myositis. Brain 142, 2590-2604. 10.1093/brain/awz207</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz207</ArticleId><ArticleId IdType="pubmed">31326977</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin, J.W., Li, C.Y., Macko, C., Ho, T.W., Hsieh, S.T., Xue, P., Wang, F.A., Cornblath, D.R., McKhann, G.M., and Asbury, A.K. (1996). Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome. J Neurocytol 25, 33-51. 10.1007/BF02284784</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02284784</ArticleId><ArticleId IdType="pubmed">8852937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafer-Macko, C., Hsieh, S.T., Li, C.Y., Ho, T.W., Sheikh, K., Cornblath, D.R., McKhann, G.M., Asbury, A.K., and Griffin, J.W. (1996a). Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40, 635-644. 10.1002/ana.410400414</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400414</ArticleId><ArticleId IdType="pubmed">8871584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafer-Macko, C.E., Sheikh, K.A., Li, C.Y., Ho, T.W., Cornblath, D.R., McKhann, G.M., Asbury, A.K., and Griffin, J.W. (1996b). Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39, 625-635. 10.1002/ana.410390512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390512</ArticleId><ArticleId IdType="pubmed">8619548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg-Oldfors, C., Lindgren, U., Visuttijai, K., Loof, D., Roos, S., Thomsen, C., and Oldfors, A. (2022). Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion. Neuropathol Appl Neurobiol 48, e12841. 10.1111/nan.12841</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12841</ArticleId><ArticleId IdType="pmc">PMC9805229</ArticleId><ArticleId IdType="pubmed">35894812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l, E.K., Harbo, T., Agergaard, J., Madsen, L.B., Pedersen, T.H., Ostergaard, L.J., Andersen, H., Schroder, H.D., and Tankisi, H. (2022). Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol 29, 2832-2841. 10.1111/ene.15435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiniker, A., Daniels, B.H., Lee, H.S., and Margeta, M. (2013). Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies. Acta Neuropathol Commun 1, 29. 10.1186/2051-5960-1-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-29</ArticleId><ArticleId IdType="pmc">PMC3893502</ArticleId><ArticleId IdType="pubmed">24252466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes, R.O., Bosanac, T., Mao, X., Engber, T.M., DiAntonio, A., Milbrandt, J., Devraj, R., and Krauss, R. (2021). Small molecule SARM1 inhibitors recapitulate the SARM1(-/-) phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep 34, 108588. 10.1016/j.celrep.2020.108588</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108588</ArticleId><ArticleId IdType="pmc">PMC8179325</ArticleId><ArticleId IdType="pubmed">33406435</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppke, P., Wegener, E., Gilley, J., Angeletti, C., Kurth, I., Drenth, J.P.H., Stadelmann, C., Barrantes-Freer, A., Bruck, W., Thiele, H., et al. (2019). Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia. Exp Neurol 320, 112958. 10.1016/j.expneurol.2019.112958</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.112958</ArticleId><ArticleId IdType="pubmed">31132363</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue, M., Noguchi, S., Inoue, Y.U., Iida, A., Ogawa, M., Bengoechea, R., Pittman, S.K., Hayashi, S., Watanabe, K., Hosoi, Y., et al. (2023). Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4. Acta Neuropathol 145, 235-255. 10.1007/s00401-022-02530-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02530-4</ArticleId><ArticleId IdType="pubmed">36512060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleefeld, F., Uruha, A., Schanzer, A., Nishimura, A., Roos, A., Schneider, U., Goebel, H.H., Schuelke, M., Hahn, K., Preusse, C., et al. (2022). Morphologic and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis. Neurology 99, e2212-e2222. 10.1212/WNL.0000000000201103</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000201103</ArticleId><ArticleId IdType="pubmed">36195449</ArticleId></ArticleIdList></Reference><Reference><Citation>Knauss, S., Preusse, C., Allenbach, Y., Leonard-Louis, S., Touat, M., Fischer, N., Radbruch, H., Mothes, R., Matyash, V., Bohmerle, W., et al. (2019). PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited. Neurol Neuroimmunol Neuroinflamm 6, e558. 10.1212/NXI.0000000000000558</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000558</ArticleId><ArticleId IdType="pmc">PMC6467687</ArticleId><ArticleId IdType="pubmed">31044146</ArticleId></ArticleIdList></Reference><Reference><Citation>Korb, M.K., Kimonis, V.E., and Mozaffar, T. (2021). Multisystem proteinopathy: Where myopathy and motor neuron disease converge. Muscle Nerve 63, 442-454. 10.1002/mus.27097</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27097</ArticleId><ArticleId IdType="pubmed">33145792</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause, K., Eggers, B., Uszkoreit, J., Eulitz, S., Rehmann, R., Guttsches, A.K., Schreiner, A., van der Ven, P.F.M., Furst, D.O., Marcus, K., et al. (2022). Target formation in muscle fibres indicates reinnervation - A proteomic study in muscle samples from peripheral neuropathies. Neuropathol Appl Neurobiol, e12853. 10.1111/nan.12853</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12853</ArticleId><ArticleId IdType="pubmed">36180966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurashige, T., Morino, H., Murao, T., Izumi, Y., Sugiura, T., Kuraoka, K., Kawakami, H., Torii, T., and Maruyama, H. (2022). TDP-43 accumulation within intramuscular nerve bundles of patients with amyotrophic lateral sclerosis. JAMA Neurol 79, 693-701. 10.1001/jamaneurol.2022.1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.1113</ArticleId><ArticleId IdType="pmc">PMC9127711</ArticleId><ArticleId IdType="pubmed">35604654</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine, T.D., and Pestronk, A. (1998). Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment. Muscle Nerve 21, 1724-1728. 10.1002/(sici)1097-4598(199812)21:12&lt;1724::aid-mus15&gt;3.0.co;2-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4598(199812)21:12&lt;1724::aid-mus15&gt;3.0.co;2-2</ArticleId><ArticleId IdType="pubmed">9843075</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Zhang, T., Li, C., Xu, W., Guan, Y., Li, X., Cheng, H., Chen, S., Yang, B., Liu, Y., et al. (2023). Electrical stimulation accelerates Wallerian degeneration and promotes nerve regeneration after sciatic nerve injury. Glia 71, 758-774. 10.1002/glia.24309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24309</ArticleId><ArticleId IdType="pubmed">36484493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukacs, M., Gilley, J., Zhu, Y., Orsomando, G., Angeletti, C., Liu, J., Yang, X., Park, J., Hopkin, R.J., Coleman, M.P., et al. (2019). Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence. Exp Neurol 320, 112961. 10.1016/j.expneurol.2019.112961</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.112961</ArticleId><ArticleId IdType="pmc">PMC6708453</ArticleId><ArticleId IdType="pubmed">31136762</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta, M. (2020). Top ten discoveries of the year: Neuromuscular disease. Free Neuropathol 1, 4. 10.17879/freeneuropathology-2020-2627</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2020-2627</ArticleId><ArticleId IdType="pmc">PMC10209959</ArticleId><ArticleId IdType="pubmed">37283670</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta, M. (2021). Neuromuscular disease: 2021 update. Free Neuropathol 2, 3. 10.17879/freeneuropathology-2021-3236</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2021-3236</ArticleId><ArticleId IdType="pmc">PMC10209996</ArticleId><ArticleId IdType="pubmed">37284616</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta, M. (2022). Neuromuscular disease: 2022 update. Free Neuropathol 3, 5. 10.17879/freeneuropathology-2022-3805</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2022-3805</ArticleId><ArticleId IdType="pmc">PMC10209905</ArticleId><ArticleId IdType="pubmed">37284156</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Aguilar, L., Lleixa, C., and Pascual-Goni, E. (2022). Autoimmune nodopathies, an emerging diagnostic category. Curr Opin Neurol 35, 579-585. 10.1097/WCO.0000000000001107</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001107</ArticleId><ArticleId IdType="pubmed">35989582</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonigal, R., Campbell, C.I., Barrie, J.A., Yao, D., Cunningham, M.E., Crawford, C.L., Rinaldi, S., Rowan, E.G., and Willison, H.J. (2022). Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barre syndrome mouse model. J Clin Invest 132, e158524. 10.1172/JCI158524</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI158524</ArticleId><ArticleId IdType="pmc">PMC9282931</ArticleId><ArticleId IdType="pubmed">35671105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocciaro, E., Runfola, V., Ghezzi, P., Pannese, M., and Gabellini, D. (2021). DUX4 role in normal physiology and in FSHD muscular dystrophy. Cells 10, 3322. 10.3390/cells10123322</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123322</ArticleId><ArticleId IdType="pmc">PMC8699294</ArticleId><ArticleId IdType="pubmed">34943834</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander, A.L., Mills, A.J., Kelley, M., Toran, L.S., Smith, B., Dalakas, M.C., and Nath, A. (2022). Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm 9, e1146. 10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterloh, J.M., Yang, J., Rooney, T.M., Fox, A.N., Adalbert, R., Powell, E.H., Sheehan, A.E., Avery, M.A., Hackett, R., Logan, M.A., et al. (2012). dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337, 481-484. 10.1126/science.1223899</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1223899</ArticleId><ArticleId IdType="pmc">PMC5225956</ArticleId><ArticleId IdType="pubmed">22678360</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva, N., Gentile, F., Cerri, F., Gallia, F., Podini, P., Dina, G., Falzone, Y.M., Fazio, R., Lunetta, C., Calvo, A., et al. (2022). Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain 145, 276-284. 10.1093/brain/awab285</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab285</ArticleId><ArticleId IdType="pmc">PMC8967102</ArticleId><ArticleId IdType="pubmed">35076694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarparanta, J., Jonson, P.H., Kawan, S., and Udd, B. (2020). Neuromuscular diseases due to chaperone mutations: A review and some new results. Int J Mol Sci 21, 1409. 10.3390/ijms21041409</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041409</ArticleId><ArticleId IdType="pmc">PMC7073051</ArticleId><ArticleId IdType="pubmed">32093037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino, S., Rossi, A.C., Smerdu, V., Leinwand, L.A., and Reggiani, C. (2015). Developmental myosins: expression patterns and functional significance. Skelet Muscle 5, 22. 10.1186/s13395-015-0046-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-015-0046-6</ArticleId><ArticleId IdType="pmc">PMC4502549</ArticleId><ArticleId IdType="pubmed">26180627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewry, C.A., Feng, L., Chambers, D., Matthews, E., and Phadke, R. (2021). Importance of immunohistochemical evaluation of developmentally regulated myosin heavy chains in human muscle biopsies. Neuromuscul Disord 31, 371-384. 10.1016/j.nmd.2021.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2021.02.007</ArticleId><ArticleId IdType="pubmed">33685841</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, Y., Kerry, P.S., Nanson, J.D., Bosanac, T., Sasaki, Y., Krauss, R., Saikot, F.K., Adams, S.E., Mosaiab, T., Masic, V., et al. (2022). Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules. Mol Cell 82, 1643-1659. 10.1016/j.molcel.2022.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.03.007</ArticleId><ArticleId IdType="pmc">PMC9188649</ArticleId><ArticleId IdType="pubmed">35334231</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, D.J., and Watkins, T.A. (2018). Therapeutic opportunities and pitfalls in the treatment of axon degeneration. Curr Opin Neurol 31, 693-701. 10.1097/WCO.0000000000000621</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000621</ArticleId><ArticleId IdType="pubmed">30320612</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanovski, I., Chintalaphani, S.R., Gamaarachchi, H., Ferguson, J.M., Pineda, S.S., Scriba, C.K., Tchan, M., Fung, V., Ng, K., Cortese, A., et al. (2022). Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci Adv 8, eabm5386. 10.1126/sciadv.abm5386</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5386</ArticleId><ArticleId IdType="pmc">PMC8896783</ArticleId><ArticleId IdType="pubmed">35245110</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallat, J.M., Magy, L., Corcia, P., Boulesteix, J.M., Uncini, A., and Mathis, S. (2020). Ultrastructural lesions of nodo-paranodopathies in peripheral neuropathies. J Neuropathol Exp Neurol 79, 247-255. 10.1093/jnen/nlz134</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlz134</ArticleId><ArticleId IdType="pubmed">31923310</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpatti, J.R., Ghahramani-Seno, M.M., Mansat, M., Sabha, N., Sarikaya, E., Goodman, S.J., Chater-Diehl, E., Celik, A., Pannia, E., Froment, C., et al. (2022). X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition. Acta Neuropathol 144, 537-563. 10.1007/s00401-022-02468-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02468-7</ArticleId><ArticleId IdType="pmc">PMC9381459</ArticleId><ArticleId IdType="pubmed">35844027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X., Jia, Y., Zhao, J., Lesner, N.P., Menezes, C.J., Shelton, S.D., Venigalla, S.S.K., Xu, J., Cai, C., and Mishra, P. (2022). A mitofusin 2/HIF1alpha axis sets a maturation checkpoint in regenerating skeletal muscle. J Clin Invest 132, e161638. 10.1172/JCI161638</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161638</ArticleId><ArticleId IdType="pmc">PMC9711883</ArticleId><ArticleId IdType="pubmed">36125902</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl, C.C., Topf, A., Bengoechea, R., Duff, J., Charlton, R., Garcia, S.K., Dominguez-Gonzalez, C., Alsaman, A., Hernandez-Lain, A., Franco, L.V., et al. (2023). Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure. Acta Neuropathol 145, 127-143. 10.1007/s00401-022-02510-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02510-8</ArticleId><ArticleId IdType="pmc">PMC9812937</ArticleId><ArticleId IdType="pubmed">36264506</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler, M., von Landenberg, C., Kappes-Horn, K., Neudecker, S., Kornblum, C., and Reimann, J. (2021). Diagnosis and clinical development of sporadic inclusion body myositis and polymyositis with mitochondrial pathology: A single-center retrospective analysis. J Neuropathol Exp Neurol 80, 1060-1067. 10.1093/jnen/nlab101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlab101</ArticleId><ArticleId IdType="pubmed">34643702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>